Showing results (1881-1890 of 5,608) with videos related to
Sort By:
Pageof 561
Nuclear Medicine Communications|April 2, 2014
Diagnostic value of 99mTc-bombesin scintigraphy for differentiation of malignant from benign breast lesionsFarzaneh Shariati, Kamran Aryana, Asiehsadat Fattahi, et al.Nuclear Medicine Communications|April 2, 2014
Frequency and significance of physiological versus pathological uptake of 68Ga-DOTATATE in the pancreas: validation with morphological imagingPaola Mapelli, Henry H Tam, Rohini Sharma, et al.Nuclear Medicine Communications|April 9, 2014
Defining PET tumor volume in cervical cancer with hybrid PET/MRI: a comparative studyShaomin Zhang, Jun Xin, Qiyong Guo, et al.Nuclear Medicine Communications|April 17, 2014
Chronic recurrent multifocal osteomyelitis: typical patterns of bone involvement in whole-body bone scintigraphyGunsel Acikgoz, Lauren W AverillNuclear Medicine Communications|April 23, 2014
Incremental value of 18F-FDG PET/CT in therapeutic decision-making of potentially curable esophageal adenocarcinomaNilendu C Purandare, C S Pramesh, George Karimundackal, et al.Nuclear Medicine Communications|February 15, 2014
Improving quantitative dosimetry in (177)Lu-DOTATATE SPECT by energy window-based scatter correctionsRobin de Nijs, Vera Lagerburg, Thomas L Klausen, et al.Nuclear Medicine Communications|March 19, 2014
Does intravenous saline infusion compromise the stability of [123I] meta-iodobenzylguanidine?Teresa Martínez, Tomás Chivato, Marta Roldán, et al.Nuclear Medicine Communications|February 25, 2017
Assessment of diabetic neuropathy with emission tomography and magnetic resonance spectroscopyHarshvardhan Rao, Neeraj Gaur, Dnyanesh TipreNuclear Medicine Communications|July 1, 1989
Does 99Tcm human serum albumin alter the characteristics of nebulized pentamidine isethionate?M J O'Doherty, S Thomas, C Page, et al.Nuclear Medicine Communications|December 16, 2016
Pretreatment metabolic parameters measured by 18F-FDG-PET to predict the outcome of first-line chemotherapy in extensive-stage small-cell lung cancerXiaozhou Yu, Yanjia Zhu, Jian Wang, et al.Pageof 561